A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)

NCT01632345 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

342

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Doravirine
DRUG: Efavirenz
DRUG: TRUVADA®
DRUG: Placebo for Doravirine
DRUG: Placebo for Efavirenz

Sponsor

Merck Sharp & Dohme LLC